These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 306324)

  • 1. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B; Jones TC; Roitt IM
    Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the K cell and the role of antibody-dependent cell mediated cytotoxicity (ADCC) in the rejection of tumours.
    Greenberg AH; Wolosin LB
    Ann Immunol (Paris); 1977; 128(1-2):485-91. PubMed ID: 848900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection.
    Nomoto K; Terasaka R; Himeno K; Shiraishi M
    Jpn J Exp Med; 1981 Apr; 51(2):81-7. PubMed ID: 6974263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody.
    Effros RB; Frankel ME; Gerhard W; Doherty PC
    J Immunol; 1979 Sep; 123(3):1343-6. PubMed ID: 313952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.
    Grimm EA; Thoma JA; Bonavida B
    J Immunol; 1979 Dec; 123(6):2870-7. PubMed ID: 315433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among differentiated T-cell subpopulations. IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K; Takeya T
    Immunology; 1979 Apr; 36(4):699-705. PubMed ID: 312268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G; Holden HT; Herberman RB
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.